Protocol tips
Upstream tips |
Protocol tips |
Downstream tips |
|
siRNA concentration-50 nM
Incubate cells for another 24h at 37°C |
|
Protocol tips |
siRNA concentration-50 nM
Incubate cells for another 24h at 37°C |
Publication protocol
To test the role of each candidate gene on cytokine production by host defense cells, we transfected siRNAs into the mouse macrophages. All siRNAs were purchased from Invitrogen. RAW264.7 cells or bone-marrow derived macrophages from C57BL/6J were transfected with 50 nM siRNA by Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions. Twenty-four hours post-transfection, cells were treated with S. aureus Bioparticles (Invitrogen) to a final concentration of 10 µg/ml. At 24 hours post-infection, supernatants were collected and stored at −80°C for Luminex-multiplex cytokine assay. In parallel experiments, cells at 3 hours post-infection were harvested for RNA extraction by RNeasy (QIAGEN), RT-PCR by SuperScript II (Invitrogen) and SYBR Green qPCR analysis (ABI) respectively. Experiments were repeated at least three times. A full list of gene names and siRNA ID numbers were in Table S1
Full paper
Login or
join for free to view the full paper.
Reviews
Dusp3 siRNA from Thermo Fisher Scientific has not yet been reviewed for this experiment
We'd love it if you would be the first to write a review!
Discussion
Start your discussion
Share your thoughts or question with experts in your field
Start a discussion
Papers
Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Mouse - BMDMs Dusp3 using Dusp3 siRNA from Thermo Fisher Scientific.
Videos
Check out videos that might be relevant for performing siRNA / miRNA gene silencing Mouse - BMDMs Dusp3 using Dusp3 siRNA from Thermo Fisher Scientific. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.
We haven't found any additional videos for this experiment / product combination yet.